Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 342.52% | 70.67% | 120.31% | 106.57% | -42.38% |
| Total Depreciation and Amortization | 2.73% | 0.85% | -0.38% | -1.22% | -1.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.52% | 2.73% | 20.84% | 30.76% | 49.03% |
| Change in Net Operating Assets | -27.23% | -313.98% | -471.88% | -1,761.33% | -132.04% |
| Cash from Operations | 23.11% | -12.00% | -2.73% | -9.04% | -14.31% |
| Capital Expenditure | -35.10% | -35.30% | -29.95% | -17.21% | -6.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -35.17% | 67.03% | 67.03% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -345.24% | -77.44% | 104.60% | 119.62% | 119.44% |
| Cash from Investing | -47.18% | -19.15% | 2.11% | -25.70% | -5.08% |
| Total Debt Issued | 9.13% | -77.72% | -55.60% | -57.17% | -71.37% |
| Total Debt Repaid | 70.69% | 78.84% | 68.06% | 67.27% | 42.79% |
| Issuance of Common Stock | 29.45% | 41.37% | 23.95% | -24.67% | -36.24% |
| Repurchase of Common Stock | -447.63% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.15% | -0.05% | -0.25% | -0.40% | -0.55% |
| Other Financing Activities | -105.60% | -105.30% | -107.10% | -105.67% | 368.97% |
| Cash from Financing | 9.52% | 30.41% | 41.95% | 33.88% | 35.39% |
| Foreign Exchange rate Adjustments | 106.21% | 117.57% | 84.48% | -29.63% | -9.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.01% | 32.31% | 89.85% | 63.40% | 68.23% |